El Nachef Laura, Bodgi Larry, Estavoyer Maxime, Buré Simon, Jallas Anne-Catherine, Granzotto Adeline, Restier-Verlet Juliette, Sonzogni Laurène, Al-Choboq Joëlle, Bourguignon Michel, Pujo-Menjouet Laurent, Foray Nicolas
INSERM U1296 Unit "Radiation: Defense, Health, Environment", Centre Léon-Bérard, 69008 Lyon, France.
Department of Radiation Oncology, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.
Cancers (Basel). 2024 Sep 18;16(18):3188. doi: 10.3390/cancers16183188.
Although carcinogenesis is a multi-factorial process, the mutability and the capacity of cells to proliferate are among the major features of the cells that contribute together to the initiation and promotion steps of cancer formation. Particularly, mutability can be quantified by hyper-recombination rate assessed with specific plasmid assay, hypoxanthine-guanine phosphoribosyltransferase (HPRT) mutations frequency rate, or MRE11 nuclease activities. Cell proliferation can be assessed by flow cytometry by quantifying G2/M, G1 arrests, or global cellular evasion.
All these assays were applied to skin untransformed fibroblasts derived from eight major cancer syndromes characterized by their excess of relative cancer risk (ERR).
Significant correlations with ERR were found between hyper-recombination assessed by the plasmid assay and G2/M arrest and described a third-degree polynomial ERR function and a sigmoidal ERR function, respectively. The product of the hyper-recombination rate and capacity of proliferation described a linear ERR function that permits one to better discriminate each cancer syndrome.
Hyper-recombination and cell proliferation were found to obey differential equations that better highlight the intrinsic bases of cancer formation. Further investigations to verify their relevance for cancer proneness induced by exogenous agents are in progress.
尽管致癌作用是一个多因素过程,但细胞的可突变性和增殖能力是细胞的主要特征,它们共同促成癌症形成的起始和促进阶段。特别是,可突变性可以通过用特定质粒检测评估的高重组率、次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶(HPRT)突变频率或MRE11核酸酶活性来量化。细胞增殖可以通过流式细胞术通过量化G2/M期、G1期阻滞或整体细胞逃逸来评估。
所有这些检测方法都应用于源自八种主要癌症综合征的未转化皮肤成纤维细胞,这些综合征的特征是相对癌症风险(ERR)过高。
通过质粒检测评估的高重组与G2/M期阻滞之间发现与ERR存在显著相关性,分别描述了三次多项式ERR函数和S形ERR函数。高重组率与增殖能力的乘积描述了一个线性ERR函数,该函数能更好地区分每种癌症综合征。
发现高重组和细胞增殖服从微分方程,这能更好地突出癌症形成的内在基础。正在进行进一步研究以验证它们对外源因素诱导的癌症易感性的相关性。